Most of the information we have on microdosing of GLP-1s is anecdotal, Zimmermann says
In the unadjusted cause-specific-hazard regression model there was no difference in the risk of suicide or suicide attempts between patients treated with GLP-1 RAs compared with patients treated with SGLT-2 inhibitors or DPP-4 inhibitors, respectively, after 1 year and 3 years of follow-up, see Table 2
Once the fake Boots Ireland advert was clicked - users were brought to an external website selling a product called "Ourlyard GLP-1 Six in One Health Solution Oral Liquid"
MHRA calls on public to report side effects and suspected fakes during MedSafetyWeek
When a small group of patients began taking a very tiny dose starting at 0.0675 mg, compared to the label-recommended 0.25 mg and increased it gradually, they were able to tolerate it better than the folks who started the usual dose and tried to escalate it in the typical way, says Alkhaddo
doi: 10.1089/dia.2014.0188